{"transactions":[{"id":712628,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-08T20:56:04.000Z","date":"2026-07-08","kind":"gift","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a bona fide gift of common stock to the Souza 2026 Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001707657-26-000008","document":"wk-form4_1783544160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000008/wk-form4_1783544160.xml","form_type":"4"}},{"id":712627,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-08T20:56:04.000Z","date":"2026-07-08","kind":"gift","planned":false,"acquired":false,"shares":20521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a bona fide gift of common stock to the Souza 2026 Trust."}],"balance_after":56495,"source":{"system":"sec-edgar","filing":"0001707657-26-000008","document":"wk-form4_1783544160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000008/wk-form4_1783544160.xml","form_type":"4"}},{"id":772126,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:42:46.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":126,"price":167.943,"value":21160.818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77016,"source":{"system":"sec-edgar","filing":"0001707657-26-000005","document":"wk-form4_1779241363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000005/wk-form4_1779241363.xml","form_type":"4"}},{"id":941032,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:48:23.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":22110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":22110,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":22110},"source":{"system":"sec-edgar","filing":"0001689548-26-000010","document":"wk-form4_1768258100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954826000010/wk-form4_1768258100.xml","form_type":"4"}},{"id":941031,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:48:23.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4252,"price":288.45,"value":1226489.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":76890,"source":{"system":"sec-edgar","filing":"0001689548-26-000010","document":"wk-form4_1768258100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954826000010/wk-form4_1768258100.xml","form_type":"4"}},{"id":941030,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:48:23.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":27640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Souza was awarded 27,640 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in\nequal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by\ndelivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":81142,"source":{"system":"sec-edgar","filing":"0001689548-26-000010","document":"wk-form4_1768258100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954826000010/wk-form4_1768258100.xml","form_type":"4"}},{"id":942143,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:46:36.000Z","date":"2026-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":405,"price":292.63,"value":118515.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":53502,"source":{"system":"sec-edgar","filing":"0001707657-26-000002","document":"wk-form4_1767995193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000002/wk-form4_1767995193.xml","form_type":"4"}},{"id":956559,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-01T00:17:43.000Z","date":"2025-12-30","kind":"gift","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred as a gift to a charitable fund."}],"balance_after":2600,"source":{"system":"sec-edgar","filing":"0001707657-25-000004","document":"wk-form4_1767226660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765725000004/wk-form4_1767226660.xml","form_type":"4"}},{"id":1142771,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:57:11.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":348,"price":31.535,"value":10974.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":53907,"source":{"system":"sec-edgar","filing":"0001689548-25-000066","document":"wk-form4_1747688224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954825000066/wk-form4_1747688224.xml","form_type":"4"}},{"id":1267348,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-14T21:29:25.000Z","date":"2025-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":85.4,"value":34245.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":53559,"source":{"system":"sec-edgar","filing":"0001689548-25-000025","document":"wk-form4_1739568557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954825000025/wk-form4_1739568557.xml","form_type":"4"}},{"id":1303486,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T23:50:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":75000,"derivative":{"exercise_price":63.15,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001689548-25-000015","document":"wk-form4_1736898649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954825000015/wk-form4_1736898649.xml","form_type":"4"}},{"id":1303485,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-14T23:50:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Souza was awarded 37,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001689548-25-000015","document":"wk-form4_1736898649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954825000015/wk-form4_1736898649.xml","form_type":"4"}},{"id":1306718,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-09T00:50:35.000Z","date":"2025-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":434,"price":77.52,"value":33643.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":16460,"source":{"system":"sec-edgar","filing":"0001689548-25-000008","document":"wk-form4_1736383828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954825000008/wk-form4_1736383828.xml","form_type":"4"}},{"id":1445315,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-01T01:03:04.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date."}],"balance_after":185000,"derivative":{"exercise_price":56.94,"expiration_date":"2034-07-29","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001104659-24-084506","document":"tm2420554-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000110465924084506/tm2420554-4_4seq1.xml","form_type":"4"}},{"id":1509030,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-20T12:10:14.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":1718,"price":12.368,"value":21248.224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":16894,"source":{"system":"sec-edgar","filing":"0001689548-24-000063","document":"wk-form4_1716207004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954824000063/wk-form4_1716207004.xml","form_type":"4"}},{"id":1643212,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-14T21:10:53.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":271,"price":44.65,"value":12100.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":15176,"source":{"system":"sec-edgar","filing":"0001689548-24-000025","document":"wk-form4_1707945012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954824000025/wk-form4_1707945012.xml","form_type":"4"}},{"id":1677939,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-17T21:49:57.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the \"Grant Date\") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":43.37,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001689548-24-000020","document":"wk-form4_1705528185.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954824000020/wk-form4_1705528185.xml","form_type":"4"}},{"id":1682742,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-10T02:09:39.000Z","date":"2024-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":418,"price":25.19,"value":10529.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":15447,"source":{"system":"sec-edgar","filing":"0001689548-24-000006","document":"wk-form4_1704852568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954824000006/wk-form4_1704852568.xml","form_type":"4"}},{"id":1843480,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-27T23:52:02.000Z","date":"2023-06-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.0587,"value":10587.0,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.045 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth."}],"balance_after":45001.75,"source":{"system":"sec-edgar","filing":"0001689548-23-000115","document":"wf-form4_168790990907113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954823000115/wf-form4_168790990907113.xml","form_type":"4"}},{"id":1886912,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-19T01:47:02.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":11687,"price":0.884,"value":10331.308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":237986,"source":{"system":"sec-edgar","filing":"0001689548-23-000090","document":"wf-form4_168446079770828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954823000090/wf-form4_168446079770828.xml","form_type":"4"}},{"id":1937946,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-27T17:12:20.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":35001.75,"price":0.863,"value":30206.51025,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8572 to $0.8676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth."}],"balance_after":35001.75,"source":{"system":"sec-edgar","filing":"0001104659-23-037023","document":"tm2310645-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000110465923037023/tm2310645-3_4seq1.xml","form_type":"4"}},{"id":1937945,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-27T17:12:20.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":0.8617,"value":30159.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.863, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth."}],"balance_after":226299,"source":{"system":"sec-edgar","filing":"0001104659-23-037023","document":"tm2310645-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000110465923037023/tm2310645-3_4seq1.xml","form_type":"4"}},{"id":2053782,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-18T00:34:50.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":425000,"derivative":{"exercise_price":2.96,"expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001689548-23-000026","document":"wf-form4_167400207336101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954823000026/wf-form4_167400207336101.xml","form_type":"4"}},{"id":2054804,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-13T12:47:34.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":213975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Souza opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022."}],"balance_after":213975,"derivative":{"exercise_price":2.96,"exercise_date":"2023-01-12","expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":213975},"source":{"system":"sec-edgar","filing":"0001689548-23-000017","document":"wf-form4_167361403910614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954823000017/wf-form4_167361403910614.xml","form_type":"4"}},{"id":2108665,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-21T11:07:00.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":2115,"price":1.811,"value":3830.265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":191299,"source":{"system":"sec-edgar","filing":"0001689548-22-000131","document":"wf-form4_166902880883749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954822000131/wf-form4_166902880883749.xml","form_type":"4"}},{"id":2173954,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-25T23:37:05.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":90000,"price":0.5608,"value":50472.0,"ownership":{"direct":true},"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001209191-22-047653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000120919122047653/doc4.xml","form_type":"4"}},{"id":2222098,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:45:18.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2.12,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001689548-22-000089","document":"wf-form4_165610350532146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954822000089/wf-form4_165610350532146.xml","form_type":"4"}},{"id":2237809,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-06-10T01:21:28.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":43000,"derivative":{"exercise_price":0.73,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001209191-22-035689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000120919122035689/doc4.xml","form_type":"4"}},{"id":2237860,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-09T23:25:09.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":27000,"price":1.8477,"value":49887.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.835 to $1.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth."}],"balance_after":189184,"source":{"system":"sec-edgar","filing":"0001689548-22-000076","document":"wf-form4_165481709561726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954822000076/wf-form4_165481709561726.xml","form_type":"4"}},{"id":2265770,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-18T21:39:42.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":1392,"price":8.798,"value":12246.816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":162184,"source":{"system":"sec-edgar","filing":"0001689548-22-000044","document":"wf-form4_165290990575398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954822000044/wf-form4_165290990575398.xml","form_type":"4"}},{"id":2437792,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T21:09:13.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":259000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":259000,"derivative":{"exercise_price":18.11,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":259000},"source":{"system":"sec-edgar","filing":"0001104659-22-003163","document":"tm222494-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000110465922003163/tm222494-5_4seq1.xml","form_type":"4"}},{"id":2437791,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-11T21:09:13.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Souza was awarded 74,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":160792,"source":{"system":"sec-edgar","filing":"0001104659-22-003163","document":"tm222494-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000110465922003163/tm222494-5_4seq1.xml","form_type":"4"}},{"id":2596229,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-19T22:33:29.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":9542,"price":15.79,"value":150668.18,"ownership":{"direct":true},"balance_after":86792,"source":{"system":"sec-edgar","filing":"0001689548-21-000077","document":"wf-form4_162941239513679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954821000077/wf-form4_162941239513679.xml","form_type":"4"}},{"id":2658890,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-06-22T20:07:02.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 36 equal monthly installments beginning on July 18, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":6.44,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-21-042377","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000120919121042377/doc4.xml","form_type":"4"}},{"id":2854995,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T21:55:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":184800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 75% vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date."}],"balance_after":184800,"derivative":{"exercise_price":52.53,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":184800},"source":{"system":"sec-edgar","filing":"0001689548-21-000010","document":"wf-form4_161359893080474.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954821000010/wf-form4_161359893080474.xml","form_type":"4"}},{"id":2854994,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T21:55:43.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":52800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Souza was awarded 52,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of February 12, 2021. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":77250,"source":{"system":"sec-edgar","filing":"0001689548-21-000010","document":"wf-form4_161359893080474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954821000010/wf-form4_161359893080474.xml","form_type":"4"}},{"id":2986645,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-10T23:51:49.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":3846,"price":26.08,"value":100303.68,"ownership":{"direct":true},"balance_after":24450,"source":{"system":"sec-edgar","filing":"0000899243-20-030741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000089924320030741/doc4.xml","form_type":"4"}},{"id":3002951,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series C -1 Preferred Stock","published_at":"2020-10-20T20:40:39.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":44092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C-1 Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-2.14 basis upon the closing of the Issuer's initial public offering on October 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C-1 Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-2.14 basis upon the closing of the Issuer's initial public offering on October 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C-1 Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-2.14 basis upon the closing of the Issuer's initial public offering on October 20, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20604},"source":{"system":"sec-edgar","filing":"0000899243-20-028742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000089924320028742/doc4.xml","form_type":"4"}},{"id":3002950,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-20T20:40:39.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":20604,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C-1 Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-2.14 basis upon the closing of the Issuer's initial public offering on October 20, 2020 and had no expiration date."}],"balance_after":20604,"source":{"system":"sec-edgar","filing":"0000899243-20-028742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000089924320028742/doc4.xml","form_type":"4"}},{"id":3277794,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2020-02-12T21:09:27.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":625,"price":12.92,"value":8075.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted on November 19, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018."}],"balance_after":3125,"derivative":{"exercise_price":12.92,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001070081-20-000059","document":"wf-form4_158154174910694.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000059/wf-form4_158154174910694.xml","form_type":"4"}},{"id":3277793,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-02-12T21:09:27.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":625,"price":53.92,"value":33700.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted on November 19, 2019."}],"balance_after":6744,"source":{"system":"sec-edgar","filing":"0001070081-20-000059","document":"wf-form4_158154174910694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000059/wf-form4_158154174910694.xml","form_type":"4"}},{"id":3277792,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-02-12T21:09:27.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":625,"price":12.92,"value":8075.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted on November 19, 2019."}],"balance_after":7369,"source":{"system":"sec-edgar","filing":"0001070081-20-000059","document":"wf-form4_158154174910694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000059/wf-form4_158154174910694.xml","form_type":"4"}},{"id":3296962,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2020-01-31T21:37:57.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":4170,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021."}],"balance_after":4170,"derivative":{"exercise_price":51.16,"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":4170},"source":{"system":"sec-edgar","filing":"0001070081-20-000043","document":"wf-form4_158050665977738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000043/wf-form4_158050665977738.xml","form_type":"4"}},{"id":3296961,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2020-01-31T21:37:57.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":93500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021."}],"balance_after":93500,"derivative":{"exercise_price":51.16,"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":93500},"source":{"system":"sec-edgar","filing":"0001070081-20-000043","document":"wf-form4_158050665977738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000043/wf-form4_158050665977738.xml","form_type":"4"}},{"id":3296960,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-31T21:37:57.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":1670,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 29, 2020 that vest in four equal installments over four years, commencing on January 29, 2021."}],"balance_after":6744,"source":{"system":"sec-edgar","filing":"0001070081-20-000043","document":"wf-form4_158050665977738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000043/wf-form4_158050665977738.xml","form_type":"4"}},{"id":3296959,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-31T21:37:57.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 29, 2020 that vest in four equal installments over four years, commencing on January 29, 2021."}],"balance_after":50097,"source":{"system":"sec-edgar","filing":"0001070081-20-000043","document":"wf-form4_158050665977738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000043/wf-form4_158050665977738.xml","form_type":"4"}},{"id":3301548,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-27T21:15:14.000Z","date":"2020-01-23","kind":"sale","acquired":false,"shares":154,"price":53.247,"value":8200.038,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 481 RSUs from a January 22, 2019 grant of 1,925 RSUs."}],"balance_after":5074,"source":{"system":"sec-edgar","filing":"0001070081-20-000025","document":"wf-form4_158015969633865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000025/wf-form4_158015969633865.xml","form_type":"4"}},{"id":3315469,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-08T23:09:15.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":86,"price":48.168,"value":4142.448,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 270 RSUs from a January 3, 2018 grant of 1,079 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 276 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2019."}],"balance_after":5228,"source":{"system":"sec-edgar","filing":"0001070081-20-000014","document":"wf-form4_157852493768998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000014/wf-form4_157852493768998.xml","form_type":"4"}},{"id":3315468,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-08T23:09:15.000Z","date":"2019-12-30","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a charitable donation by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 276 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2019."}],"balance_after":37497,"source":{"system":"sec-edgar","filing":"0001070081-20-000014","document":"wf-form4_157852493768998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000014/wf-form4_157852493768998.xml","form_type":"4"}},{"id":3331566,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":6250,"price":12.92,"value":80750.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The transactions of the Reporting Person's spouse reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on November 19, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018."}],"balance_after":3750,"derivative":{"exercise_price":12.92,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331565,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":30000,"price":18.01,"value":540300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019."}],"balance_after":45000,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331564,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":15881,"price":11.23,"value":178343.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018."}],"balance_after":7219,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":15881},"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331563,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":30000,"price":12.53,"value":375900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Currently exerciseable."}],"balance_after":0,"derivative":{"exercise_price":12.53,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331562,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":6250,"price":48.8,"value":305000.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The transactions of the Reporting Person's spouse reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on November 19, 2019."}],"balance_after":5038,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331561,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":6250,"price":12.92,"value":80750.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The transactions of the Reporting Person's spouse reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on November 19, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 371 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2019."}],"balance_after":11288,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331560,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":18668,"price":49.19,"value":918278.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.82 to $49.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38221,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331559,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":11332,"price":48.431,"value":548820.092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.82 to $48.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":56889,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331558,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":30000,"price":18.01,"value":540300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."}],"balance_after":68221,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331557,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":7004,"price":49.319,"value":345430.276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $49.03 to $49.65 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38221,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331556,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":8877,"price":48.58,"value":431244.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.02 to $49.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":45225,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331555,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":15881,"price":11.23,"value":178343.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."}],"balance_after":54102,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331554,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":21271,"price":49.14,"value":1045256.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.77 to $49.65 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38221,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331553,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":8729,"price":48.321,"value":421794.009,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.77 to $48.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":59492,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331552,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":30000,"price":12.53,"value":375900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."}],"balance_after":68221,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331551,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":14814,"price":49.141,"value":727974.774,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.77 to $49.65 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38221,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3331550,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-26T22:24:32.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":6000,"price":48.322,"value":289932.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.75 to $48.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 371 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2019."}],"balance_after":53035,"source":{"system":"sec-edgar","filing":"0001070081-19-000061","document":"wf-form4_157739905265156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000061/wf-form4_157739905265156.xml","form_type":"4"}},{"id":3503130,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-06-05T01:09:38.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":5490,"price":40.38,"value":221686.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 15,000 shares of restricted stock from a May 31, 2017 grant of 30,000 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018 and 368 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2018."}],"balance_after":58664,"source":{"system":"sec-edgar","filing":"0001070081-19-000036","document":"wf-form4_155969696332378.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000036/wf-form4_155969696332378.xml","form_type":"4"}},{"id":3688299,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T22:45:36.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":6825,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":6825,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":6825},"source":{"system":"sec-edgar","filing":"0001104659-19-003196","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465919003196/a4.xml","form_type":"4"}},{"id":3688298,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T22:45:36.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023."}],"balance_after":25000,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-19-003196","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465919003196/a4.xml","form_type":"4"}},{"id":3688297,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T22:45:36.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":112500,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001104659-19-003196","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465919003196/a4.xml","form_type":"4"}},{"id":3688296,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-24T22:45:36.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":1925,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020."}],"balance_after":4667,"source":{"system":"sec-edgar","filing":"0001104659-19-003196","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465919003196/a4.xml","form_type":"4"}},{"id":3699258,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-09T22:12:51.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":83,"price":34.75,"value":2884.25,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 269 RSUs from a January 3, 2018 grant of 1,079 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018 and 368 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2018."}],"balance_after":2742,"source":{"system":"sec-edgar","filing":"0001070081-19-000011","document":"wf-form4_154707195442272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008119000011/wf-form4_154707195442272.xml","form_type":"4"}},{"id":3909047,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-06-04T20:22:34.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":5161,"price":34.65,"value":178828.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 15,000 shares of restricted stock from a May 31, 2017 grant of 30,000 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Includes 30,000 shares of a restricted stock award awarded to the Reporting Person on May 31, 2017 and reported on the Form 4 filed by the Reporting Person on June 2, 2017, which shares were inadvertently not previously included in Column 5 of Table 1 on such Form 4."}],"balance_after":63071,"source":{"system":"sec-edgar","filing":"0001070081-18-000052","document":"wf-form4_152814373741541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008118000052/wf-form4_152814373741541.xml","form_type":"4"}},{"id":4105894,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2018-01-05T21:08:06.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":2696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019."}],"balance_after":2696,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2696},"source":{"system":"sec-edgar","filing":"0001070081-18-000017","document":"wf-form4_151518647228588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008118000017/wf-form4_151518647228588.xml","form_type":"4"}},{"id":4105893,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2018-01-05T21:08:06.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019."}],"balance_after":75000,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001070081-18-000017","document":"wf-form4_151518647228588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008118000017/wf-form4_151518647228588.xml","form_type":"4"}},{"id":4105892,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-05T21:08:06.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":1079,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017."}],"balance_after":1742,"source":{"system":"sec-edgar","filing":"0001070081-18-000017","document":"wf-form4_151518647228588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008118000017/wf-form4_151518647228588.xml","form_type":"4"}},{"id":4296428,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-06-02T22:54:35.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":30000,"price":12.53,"value":375900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 31, 2017, and vests in two equal annual installments over two years, commencing on May 31, 2018."}],"balance_after":30000,"derivative":{"exercise_price":12.53,"expiration_date":"2017-05-31","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001070081-17-000096","document":"wf-form4_149644405900854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000096/wf-form4_149644405900854.xml","form_type":"4"}},{"id":4296427,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-06-02T22:54:35.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock awarded to the Reporting Person vests in two equal annual installments over two years, commencing on May 31, 2018."}],"balance_after":36457,"source":{"system":"sec-edgar","filing":"0001070081-17-000096","document":"wf-form4_149644405900854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000096/wf-form4_149644405900854.xml","form_type":"4"}}]}